UOC
MNTA

UBS O'Connor’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

UBS O'Connor’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-609,282
Closed -$32M – 683
2020
Q3 		$32M Buy
+609,282
New +$25.2M 0.81% 23

UBS O'Connor's MNTA Position: Q4 2020 in Review

UBS O'Connor sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 609,282 shares — an estimated $32M sold.

UBS O'Connor first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $32M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • UBS O'Connor reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • UBS O'Connor sold 609,282 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $32M.
  • UBS O'Connor first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • UBS O'Connor's Momenta Pharmaceuticals, Inc. position peaked at $32M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on UBS O'Connor's 13F filing for Q4 2020, filed 17 Feb 2021.